The World Health Organization said that testing of the drug in its large multi-country trial of treatments for COVID-19 patients had been halted after results from other trials showed no benefit.
The World Health Organization said on Wednesday that testing of the malaria drug hydroxychloroquine in its large multi-country trial of treatments for COVID-19 patients had been halted after results from other trials showed no benefit.
"The hydroxychloroquine arm of the SOLIDARITY trial has been stopped," WHO expert Ana Maria Henao-Restrepo told a news briefing.
Comments
0 comment